Advertisement

GSK backs out of Ulverston site investment

Pharmaceutical giant, GSK, has backed out of its formerly proposed £350million investment into its site at Ulverston, Cumbria. The funds were going to a new biopharma drugs facility.

View all 3 updates ›

Tim Farron: GSK should leave 'dowry' for site's future investment and jobs

GSK pulled out of a planned £350million investment in the Ulverston site Credit: GSK

South Lakeland MP Tim Farron has called for pharmaceutical company GlaxoSmithKline (GSK) to leave a dowry behind to make future investment in the site more attractive for a potential buyer and to support local jobs.

This week GSK shocked the area by pulling out of a planned £350million investment in the Ulverston site which would have supported hundreds of local jobs.

Tim Farron says the local community is still reeling from the news:

People feel betrayed and many residents are understandably concerned about the impact on jobs. GSK should commit to leaving a substantial dowry of several million pounds, to show good faith to the local community.

Leaving even a fraction of the £350million that GSK would have invested would help to support local jobs and partially compensate local residents for this blow. Our local community has shown deep commitment to GSK. GSK must now show an ongoing commitment to our community. Anything else will be an appalling betrayal.”

– Tim Farron, South Lakeland MP

More top news